Targeting MET: Discovery of Small Molecule Inhibitors as Non-Small Cell Lung Cancer Therapy-Reference-Cited by-同舟云学术

Targeting MET: Discovery of Small Molecule Inhibitors as Non-Small Cell Lung Cancer Therapy

Published:2023-06-01 Issue:12 Volume:66 Page:7670-7697
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wang Chaofan¹,Lu Xiaoyun²¹^ORCID

Affiliation:

1. International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education (MOE), School of Pharmacy, Jinan University, #855 Xingye Avenue, Guangzhou, 510632, China

2. State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou 450001, China

Funder

State Key Laboratory of Respiratory Disease

Jinan University

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

State Key Laboratory of Esophageal Cancer Prevention and Treatment

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00028

Reference218 articles.

1. Targeting MET in cancer: rationale and progress

2. MET As a Possible Target for Non–Small-Cell Lung Cancer

3. MET molecular mechanisms and therapies in lung cancer

4. Tyrosine kinase receptor indistinguishable from the c-met protein

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDA-approved small molecule kinase inhibitors for cancer treatment (2001–2015): Medical indication, structural optimization, and binding mode Part I;Bioorganic & Medicinal Chemistry;2024-09

2. Design and Synthesis of c-Met and HDAC Dual Inhibitors for the Treatment of Breast Cancer;ACS Medicinal Chemistry Letters;2024-08-22

3. Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning;2024-07-18

4. Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment;Journal of Medicinal Chemistry;2024-07-04

5. Synthetic Approaches to the New Drugs Approved During 2022;Journal of Medicinal Chemistry;2024-03-15